Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma
Open Access
- 1 June 1999
- Vol. 1 (2) , 162-169
- https://doi.org/10.1038/sj.neo.7900016
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Treatment of Human Breast Cancer in a Brain Metastatic Model by G207, a Replication-Competent Multimutated Herpes Simplex Virus 1Human Gene Therapy, 1998
- An oncolytic viral mutant that delivers the CYP2B1 transgene and augments cyclophosphamide chemotherapyNature Biotechnology, 1998
- Enhancement of replication of genetically engineered herpes simplex viruses by ionizing radiation: a new paradigm for destruction of therapeutically intractable tumorsGene Therapy, 1998
- Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukinsGene Therapy, 1998
- Antitumor activity of cis-diamminedichloroplatinum II against human tumor xenografts depends on its area under the curve in nude miceJournal of Surgical Oncology, 1996
- Head and Neck CancerNew England Journal of Medicine, 1993
- Induction Chemotherapy plus Radiation Compared with Surgery plus Radiation in Patients with Advanced Laryngeal CancerNew England Journal of Medicine, 1991
- Chemotherapy for head and neck cancer.Comparison of cisplatin + vinblastine + bleomycin versus methotrexateCancer, 1986
- Chemotherapy in Head and Neck CancerNew England Journal of Medicine, 1983
- Symposium: Adjuvant cancer therapy of head and neck tumors. Increased survival with surgery alone vs. Combined therapyThe Laryngoscope, 1979